NCT00450372
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
Clinical trial condition
Neuroendocrine Tumors
Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.
2,768 public trials
494 recruiting studies
Neuroendocrine Tumors trial results
NCT01121718
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
NCT00358956
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +17 more
- Locations
-
- Research Site Little Rock, Arkansas, United States
- Research Site Boston, Massachusetts, United States
- Research Site St Leonards, Australia
- Research Site Sherbrooke, Quebec, Canada
NCT02437305
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Northwestern University Department of Dermatology Chicago, Illinois, United States
NCT02406183
- Conditions
- Adverse Effect of Radiation Therapy, Effects of Immunotherapy, Melanoma, +13 more
- Locations
-
- Dept. of Radiotherapy, Ghent University Hospital Ghent, Oost-Vlaanderen, Belgium
NCT02829775
- Conditions
- Adenocarcinoma, Bone Marrow Diseases, Carcinoma, +36 more
- Locations
-
- Sofia, Bulgaria
- Halifax, Nova Scotia, Canada
- Lucknow, India
- Moscow, Russia
NCT01974752
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +16 more
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site Aurora, Colorado, United States
- Research Site Atlanta, Georgia, United States
- Research Site Lutherville, Maryland, United States
NCT00109005
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +14 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
NCT01477463
- Conditions
- Melanoma, Melanoma, Skin, Neoplasms, +10 more
- Locations
-
- Stanford University Cancer Institute Palo Alto, California, United States
Completed
IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma
NCT01189383
- Conditions
- Malignant Melanoma Stage III, Malignant Melanoma Stage IV, Melanoma, +11 more
- Locations
-
- Baylor University Medical Center Dallas, Texas, United States